HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $201,000 | -48.3% | 3,244 | -33.4% | 0.01% | -43.5% |
| Q2 2022 | $389,000 | -8.9% | 4,873 | +20.2% | 0.02% | +21.1% |
| Q1 2022 | $427,000 | +7.6% | 4,054 | +10.0% | 0.02% | +35.7% |
| Q4 2021 | $397,000 | -8.7% | 3,687 | -7.1% | 0.01% | -6.7% |
| Q3 2021 | $435,000 | +17.3% | 3,967 | 0.0% | 0.02% | +25.0% |
| Q2 2021 | $371,000 | +1.6% | 3,967 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $365,000 | -15.7% | 3,967 | -33.0% | 0.01% | -20.0% |
| Q4 2020 | $433,000 | -99.0% | 5,917 | -98.9% | 0.02% | -99.2% |
| Q3 2020 | $42,735,000 | +3.6% | 550,145 | -25.8% | 1.89% | -2.7% |
| Q2 2020 | $41,231,000 | +25.0% | 741,837 | -33.4% | 1.95% | -5.9% |
| Q1 2020 | $32,975,000 | -23.2% | 1,113,281 | -6.1% | 2.07% | +17.9% |
| Q4 2019 | $42,916,000 | +33.1% | 1,185,516 | +0.1% | 1.75% | +22.8% |
| Q3 2019 | $32,234,000 | +12.7% | 1,183,779 | -0.4% | 1.43% | +25.6% |
| Q2 2019 | $28,604,000 | – | 1,188,856 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |